Rossaphorn Kittiyaowamarn

机构：Ministry of Public Health · ORCID：0000-0001-9382-7776

发表论文 23 篇 · 总被引 169 次 · h-index 8

代表论文

• Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial (2025 · The Lancet · 被引 40)
• High In Vitro Susceptibility to the First-in-Class Spiropyrimidinetrione Zoliflodacin among Consecutive Clinical Neisseria gonorrhoeae Isolates from Thailand and South Africa (2019 · Antimicrobial Agents and Chemotherapy · 被引 22)
• Innovations in the biomedical prevention, diagnosis, and service delivery of HIV and other sexually transmitted infections (2025 · The Lancet · 被引 20)
• Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018 (2022 · Journal of Antimicrobial Chemotherapy · 被引 17)
• Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin (2024 · BMC Global and Public Health · 被引 14)
• Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study (2025 · The Lancet Regional Health - Western Pacific · 被引 11)